Replies to post #575536 on NorthWest Biotherapeutics Inc (NWBO)

[dennisdave]

After MIA and submission of requests for approval with all RA's (i am predicting this to happen before May 14), we will see a rapid SP increase.

Also it would be ridiculous to assume that a large investor would come in at 50 cents after MHRA approval as you suggest since the market cap will be at least $ 3 billion after MHRA approval and not $500 million.

50 per month without reimbursements is highly unlikely. Not happening this year guaranteed!

I suspect that of all GBM patients, 20-25% will be able to pay $150k from their private funds. So disagree

[aesop1]

You can already see the finances getting tighter in the dev bios. A lot of small bios downsizing programs, merging with other small bios, and bankruptcies. Even the great thermo acknowledged NWBO has problems with their timelines. The specials program is not about making revenue 100%. Approval with reimbursement/coverage is how you generate revenue and if you are expecting big UK revenue......in for a rude awakening. Years and years needed here. All this speculative talk of ILAP and Orbis, give me a break.....NWBO isnt even FDA RMAT designated. That is what you get if you are a break thru cell therapy bio.


Two left feet....cant execute in any semblance of a timely fashion.

[DavidW2]

I wonder why you are investing on NWBO at this moment? If this is so bearish and hard to get funding, you should invest on many other stocks which has better return in 1-2 years. Why keeps waiting on here and watch stock going lower and don't expect any nice return in a year? This is not making any sense....